MOLECULIN BIOTECH INC
MOLECULIN BIOTECH INC
Share · US60855D2009 · MBRX · A2QQM0 (XNAS)
Overview Financial Indicators
0,64 USD
-5,59 % -0,04 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
13.06.2025 23:45

Current Prices from MOLECULIN BIOTECH INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
MBRX
USD
13.06.2025 23:45
0,64 USD
0,66 USD
-1,98 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -4,89 % -35,80 % -43,03 % -72,45 % -84,49 % -99,36 %

Company Profile for MOLECULIN BIOTECH INC Share

Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and other malignancies. It also develops WP1220, an analog of WP1066 for the topical treatment of cutaneous T-cell lymphoma; and WP1122 to treat glioblastoma multiforme and COVID-19. The company has partnership and collaboration agreements with MD Anderson; Animal Life Sciences, LLC; and WPD Pharmaceuticals Sp z.o.o. Moleculin Biotech, Inc. was incorporated in 2015 and is headquartered in Houston, Texas.

Company Data

Name MOLECULIN BIOTECH INC
Company Moleculin Biotech, Inc.
Symbol MBRX
Website https://www.moleculin.com
Primary Exchange XNAS NASDAQ
WKN A2QQM0
ISIN US60855D2009
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Walter V. Klemp
Market Capitalization 12 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 5300 Memorial Drive, 77007 Houston
IPO Date 2016-06-02

Stock Splits

Date Split
22.03.2024 1:15
01.02.2021 1:6

Ticker Symbols

Name Symbol
NASDAQ MBRX

More Shares

Investors who MOLECULIN BIOTECH INC hold also have the following shares in their portfolio:
AMAG LEASING 19/22
AMAG LEASING 19/22 Bond
Keeley Mid Cap Dividend Value Fund Class A
Keeley Mid Cap Dividend Value Fund Class A Fund
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025